Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together
The healthcare landscape has never been more complex, with an aging population and a rise in complex and chronic conditions requiring specialized care.
Advanced therapies, including biologics and cell and gene therapies, are gaining momentum, with
25% of all FDA-approved cell and gene therapies approved within the last 18 months. New treatments, such as glucagon-like peptide-1 receptor agonists (GLP-1s) for weight loss, are also on the rise.
- Advanced therapies make up an increasing percentage of new approvals.
- Biologics, such as GLP-1s, are gaining market share.
- Prescriptions for specialty medications have risen dramatically over the past five years.
Author's summary: Community pharmacies simplify patient care in complex healthcare.
More News
- Jay Glazer says Eagles won't trade A.J. Brown, are interested in Jaelan Phillips | NorthPennNow
- OP-ED: Trump’s trade deals are reshaping America’s critical minerals future
- Jumhouria Bank denies opening letters of credit for school textbooks amid controversy
- University of Alabama Investigating Alleged Incident Involving Dre Kirkpatrick Jr.